TABLE 1.
The Relationship of Clinical Variables to Survival
| Variable and Group | No. | Survival | Significance |
|---|---|---|---|
| Age (yr) | |||
| >60 | 26 | 81.3% | |
| 50–60 | 46 | 75.4% | |
| <50 | 100 | 72.5% | 0.5787 |
| Previous surgery | |||
| None | 71 | 80.7% | |
| (R) Upper abdomen | 36 | 67.9% | |
| Other | 35 | 67.3 | 0.1220 |
| Pathologic staging* | |||
| Stage 3 | 21 | 77.8% | |
| Stage 4 | 117 | 73.6% | 0.8239–0.6453* |
| Ascites | |||
| Controlled | 63 | 64.9% | |
| Uncontrolled | 8 | 88.9% | |
| None | 70 | 82.4% | 0.0165 |
| Total bilirubin (mg/dl) | |||
| >20 | 32 | 66.7% | |
| 10–20 | 65 | 75.6% | |
| 2–10 | 37 | 78.7% | |
| <2 | 8 | 88.9% | 0.3857 |
| Prothrombin time (sec) | |||
| >15 | 10 | 55.6% | |
| <15 | 129 | 77.2% | 0.0826–0.0431† |
| Creatinine (mg/dl): | |||
| >1.3 | 10 | 58.8% | |
| <1.3 | 128 | 76.6% | 0.1859–0.1059† |
| Liver weight (native hepatectomy specimen) (% of body weight) |
|||
| >3.5 | 56 | 77.8% | |
| 2.5–3.5 | 54 | 77.1% | |
| <2.5 | 31 | 66.0% | 0.2900 |
*
No patients at stage 2 or 3 were transplanted at our center.
†
Before the Yates correction.